AAD
  • Registration
  • Daily Coverage
  • Industry Highlights
  • Product Samples
  • Program
  • Photo Gallery
Topics
  • Daily Coverage
  • Industry Highlights
  • Product Samples
  • Program
  • Photo Gallery
Resources
  • Registration
Facebook iconInstagram iconTwitter X icon
Feb 14, 2022

Novel uses for JAK inhibitors part of comprehensive What’s New session

Pathogenesis-directed drug therapy is only beginning to find a role in dermatology.


Seemal R. Desai, MD, FAAD.
Seemal R. Desai, MD, FAAD.

S062 – What’s New in Dermatology

Tuesday, March 29 | 8 a.m. – 10 a.m.

Ballroom West

Hope is on the horizon for patients seeking relief from the symptoms related to vitiligo, atopic dermatitis, alopecia, and psoriasis, and that hope may just come in the form of a pathogenesis-directed drug therapy long used to treat rheumatoid arthritis — Janus kinase (JAK) inhibitors.

The 2022 AAD Annual Meeting will shed light on that discovery and more during the session, S062 – What’s New in Dermatology. JAK inhibitors are only beginning to find a role in dermatology and will provide new treatment opportunities for dermatologists and patients alike, according to session panelist, Seemal R. Desai, MD, FAAD, founder and medical director of Innovative Dermatology PA in Plano, Texas.

“The JAK inhibitor baricitinib will be the first FDA-approved therapy for alopecia areata ever,” Dr. Desai said of the disease that takes an emotional toll on patients. “We don’t have an exact date yet, but the data look good.”

In the fall of 2021, the FDA approved the use of JAK inhibitors in topical form for atopic dermatitis, he said. Soon, the FDA is expected to approve the use of JAK inhibitors to treat vitiligo and issue its approval for the JAK inhibitor deucravactinib to treat psoriasis, Dr. Desai said.

In addition to the closer look at the use of JAK inhibitors in dermatology, the Tuesday, March 29 session is wide-ranging and will explore an array of updates by noted speakers:

  • What's New in Psoriasis?: Bruce Elliot Strober, MD, PhD, FAAD
  • What's New in Surgical Dermatology?: Brett M. Coldiron, MD, FAAD
  • What's New in the Diagnosis and Treatment of Cutaneous Malignancy?: Darrell S. Rigel, MD, FAAD
  • What's New in Cosmetic Dermatology?: Mark S. Nestor, MD, PhD, FAAD
  • What's New in Pediatric Dermatology?: Lawrence F Eichenfield, MD, FAAD
  • What's New in Mild to Moderate Psoriasis?: Linda F. Stein Gold, MD, FAAD
  • What's New in Systemic Dermatologic Therapy?: Seemal R. Desai, MD, FAAD

There will also be a Q&A with session director, Mark Lebwohl, MD, FAAD. 

Visit AAD DermWorld Meeting News Central for more articles.

Interesting Stories
<i>DermWorld</i> July | Supplements and the skin
Presented by AAD
DermWorld July | Supplements and the skin
<i>DermWorld</i> June | Problematic in Pregnancy
Presented by AAD
DermWorld June | Problematic in Pregnancy
Quick tips for navigating the Innovation Academy
Presented by Dermavant
Quick tips for navigating the Innovation Academy
Unveiling the potential of the aryl hydrocarbon receptor
Presented by Dermavant
Unveiling the potential of the aryl hydrocarbon receptor
More in Daily Coverage
2 J6 A5263
Innovation Academy 2023
Successful 2023 Innovation Academy closes the gap on learning
Aug 18, 2023
2022 03 21 12 26 25 6238b55bf2d38 640e3f2761020
Innovation Academy 2023
2023 Innovation Academy: Claim CME
Aug 18, 2023
Kenneth J. Tomecki, MD, FAAD
Innovation Academy 2023
Science backs vitamin treatment for pediatric eczema
Aug 18, 2023
Keyvan Nouri, MD, MBA, FAAD
Innovation Academy 2023
Business as usual?
Aug 18, 2023
M. Laurin Council, MD, MBA, FAAD
Innovation Academy 2023
On the rare side of skin cancer
Aug 18, 2023
Carolyn Goh, MD, FAAD
Innovation Academy 2023
More than a head of hair
Aug 18, 2023
Gil Yosipovitch, MD, FAAD
Innovation Academy 2023
Don’t ignore the power and persistence of itch
Aug 18, 2023
Jennifer Hsiao, MD, FAAD
Innovation Academy 2023
Hidradenitis suppurativa: Clinical pearls from your peers
Aug 12, 2023
Left to right: Charlene Lam, MD, MPH, FAAD, and Alexandra Flamm, MD, FAAD
Innovation Academy 2023
Learn to lead — and adapt
Aug 12, 2023
Barbara Ann Gilchrest, MD, FAAD
Innovation Academy 2023
Better sunscreen education applies to all
Aug 12, 2023
Ginette Okoye, MD, FAAD
Innovation Academy 2023
Stepping up for the underserved
Aug 12, 2023
Alice B. Gottlieb, MD, PhD, FAAD
Innovation Academy 2023
What we’ve learned about psoriatic arthritis
Aug 12, 2023
AAD
Facebook iconInstagram iconTwitter X icon
© Ascend Media All rights reserved. DermWorld Meeting News Central is a publication of the American Academy of Dermatology.